UNITED BIOMEDICAL INC ASA UBI ASIA

Company Type: Manufacturer (Factory)

UNITED BIOMEDICAL INC ASA UBI ASIA (UBI Asia) is a biotechnology company headquartered in Taiwan. It primarily operates as a manufacturer, deeply involved in the research, development, and production of a diverse range of biopharmaceutical products. UBI Asia's main focus areas include infectious disease diagnostics, vaccine development, and therapeutic drug research and manufacturing. The company is dedicated to utilizing innovative biotechnologies to address critical medical needs and enhance global health outcomes. While UBI Asia also handles the commercialization and distribution of its products, its core identity is that of an R&D-driven manufacturer.

United Biomedical Inc. Asia (UBI Asia) specializes in the research, development, and manufacturing of synthetic peptide-based vaccines and diagnostic products. Its primary product offerings include:

1. Diagnostic Products

UBI Asia produces a wide range of enzyme-linked immunosorbent assays (ELISA) for the detection of infectious diseases. Key products include:

- UBI HIV-1/2 EIA: A diagnostic test for the detection of antibodies to HIV-1 and HIV-2.

- UBI HCV EIA: A diagnostic test for the detection of antibodies to the Hepatitis C virus.

- UBI HTLV-I/II EIA: A diagnostic test for the detection of antibodies to Human T-cell Lymphotropic Virus types I and II.

2. Veterinary Vaccines

The company is well-known for its proprietary synthetic peptide vaccine technology applied to animal health, including:

- FMD Vaccine: Foot-and-Mouth Disease vaccines developed using synthetic peptide technology, designed to be DIVA-compatible (Differentiating Infected from Vaccinated Animals).

- Porcine Circovirus Vaccine: Vaccines targeting PCV2 for swine health.

3. Research and Development Services

- Synthetic Peptide Manufacturing: UBI Asia provides custom synthesis of high-purity peptides for research and clinical applications.

- Immunological Reagents: Production of various antigens and antibodies used in diagnostic and therapeutic research.

4. Pharmaceutical Development

- The company focuses on the development of immunotherapeutic agents and vaccines for chronic diseases, leveraging its UBITh platform (a proprietary technology for site-directed immunomodulation).